Page 45 - Mobile Opera News Today

The Lighthouse Guild has opened its Technology Center in New York City, offering access to the latest assistive devices and technology for people with visual impairments.Healio/OSN spoke with Lighthouse Guild president and CEO Calvin W. Roberts, MD, about the Technology Center and what people can expect from the new venture.

Besides making sure each foot lands in front of the other, there isn’t much you can do during a 26.2-mile run other than let your mind wander. Howard Weinstein, MD, director of the pediatric hematology-oncology program at MassGeneral Hospital for Children Cancer Center, often thinks about each patient he’s run for at the Boston Marathon and the many others he’s treated

Long-term CT abnormalities were common up to 1 year after COVID-19 pneumonia in a study published in Radiology.Researchers performed a secondary analysis of CovILD, a prospective, multicenter, observational cohort study, conducted from April to August 2020. The study evaluated pulmonary abnormalities on chest CT at 2, 3 and 6 months and 1 year after COVID-19 symptoms in 142 adults who had mild to

WASHINGTON — Sodium thiosulfate, administered before and after reperfusion for STEMI, did not improve infarct size between 4 months and 2 years compared with placebo, a speaker reported.The GIPS-IV trial is the first to assess the use of sodium thiosulfate, or any hydrogen sulfide-donating compounds, for the treatment of STEMI in humans, according to a presentation at the American College

The FDA has granted an orphan drug designation for biotherapeutics firm aTyr’s potential first-in-class immunomodulator efzofitimod in the treatment of systemic sclerosis, according to a company press release.

Published results showed intra-articular injections of leukocyte-rich platelet-rich plasma had similar clinical improvements as leukocyte-poor PRP injections in patients with symptomatic knee osteoarthritis. Researchers randomly assigned 192 patients with symptomatic knee OA to receive three weekly injections of either leukocyte-rich PRP or leukocyte-poor PRP. Researchers evaluated IKDC

The AGA has issued a clinical practice update on de-prescribing proton pump inhibitors, according to an article in Gastroenterology.

Environmental contamination was the primary source of microbes found on contact lens surfaces, highlighting the need for better patient education regarding lens handling and hygiene, according to a study published in Heliyon.

SEATTLE — MRI biomarkers were significantly associated with glial tau pathology and could aid in the diagnosis of certain neurodegenerative diseases, a presenter said at the 2022 American Academy of Neurology annual meeting. “Progressive supranuclear palsy and corticobasal degeneration are the two most common sporadic forms [of four-repeat tauopathies]. They share overlapping

With the aid of $17 million in grant funding, UCSF Benioff Children’s Hospital Oakland will initiate a 4-year trial evaluating CRISPR/Cas9 gene editing as a potential cure for sickle cell disease.Researchers at the institution have received a grant of $8.4 million from the California Institute for Regenerative Medicine and one of $8.6 million from the NIH Cure Sickle Cell Initiative, which